Metabolic Syndrome and the Risk of Depression and Anxiety: A Prospective Cohort Study
This prospective cohort study of over 316,000 participants demonstrates that metabolic syndrome significantly increases the risk of developing new-onset depression and anxiety through a dose-response relationship, with central obesity and low HDL cholesterol being key drivers and systemic inflammation partially mediating this association.